Advaxis Competitors and Similar CompaniesClear all
Marker Therapeutics's competitors and similar companies include MOLOGEN.
 Marker Therapeutics Marker Therapeutics is a biopharmaceutical company engaged in the discovery and development of immunotherapeutics for the treatment of cancer, infectious diseases, autoimmune disorders, and transplant tissue rejection. |  MOLOGEN MOLOGEN AG is a biotechnology company specializing in the research and clinical development of innovative drugs in the fields of oncology and infectious diseases. | |
Founding Date | Founding Date 2018 | Founding Date 1998 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Houston, US HQ | Locations Berlin, DE HQ |
Employees | Employees 888% decrease | Employees 4710% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) $3.5m (FY, 2025) | Revenue (est.) €81k (FY, 2019) |
Net income | Net income ($12.2m) (FY, 2025) | Net income (€10.3m) (FY, 2019) |
For sources of this data, please see the company profile
View Company Profiles
MOLOGEN
HQ
Berlin, DE
Employees
47↓ 10% decrease
MOLOGEN AG is a biotechnology company specializing in the research and clinical development of innovative drugs in the fields of oncology and infectious diseases.
View company